515 results on '"Jöhrens, Korinna"'
Search Results
2. Testung auf Mismatch-Reparatur-Defizienz und Mikrosatelliteninstabilität: Eine fokussierte Aktualisierung
3. Prognostic value of regulatory T cells and T helper 17 cells in high grade serous ovarian carcinoma
4. Erratum zu: Testung auf Mismatch-Reparatur-Defizienz und Mikrosatelliteninstabilität
5. Molecular subtyping of head and neck cancer – Clinical applicability and correlations with morphological characteristics
6. The value of subcutaneous xenografts for individualised radiotherapy in HNSCC: Robust gene signature correlates with radiotherapy outcome in patients and xenografts
7. Routineuntersuchungen der Pathologie für die Therapie mit modernen Medikamenten
8. Ringversuche – ein zentrales Mittel der externen Qualitätssicherung
9. Human glycoprotein-2 expressed in Brunner glands – A putative autoimmune target and link between Crohn's and coeliac disease
10. Neurotrophic-tyrosine receptor kinase gene fusion in papillary thyroid cancer: A clinicogenomic biobank and record linkage study from Finland
11. Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations
12. Nachweis der BRAF-V600E-Mutation beim metastasierten kolorektalen Karzinom: Ein QuIP-Ringversuch
13. Treatment options for critical size defects - Comparison of different materials in a calvaria split model in sheep
14. MSI testing: What’s new? What should be considered?
15. Status quo of ALK testing in lung cancer: results of an EQA scheme based on in-situ hybridization, immunohistochemistry, and RNA/DNA sequencing
16. MSI-Testung: Was ist neu? Was ist zu beachten?
17. Qualitätssicherung in der dMMR- und MSI-Diagnostik
18. Lymphoproliferative Erkrankungen der Mundhöhle und des Waldeyer Rachenrings
19. Favorable therapeutic response after anti-Mesothelin antibody–drug conjugate treatment requires high expression of Mesothelin in tumor cells
20. Qualitätssicherung in der diagnostischen In-situ-Hybridisierung – Erfahrungen der QuIP
21. Prognosis of patients with malignant mesothelioma by expression of programmed cell death 1 ligand 1 and mesothelin in a contemporary cohort in Finland
22. Testing deficient mismatch repair and microsatellite instability
23. Clinical Impact of Rare and Compound Mutations of Epidermal Growth Factor Receptor in Patients With Non–Small-Cell Lung Cancer
24. Morphomolecular analysis of the immune tumor microenvironment in human head and neck cancer
25. Prognostic impact of the post-treatment T cell composition and spatial organization in soft tissue sarcoma patients treated with neoadjuvant hyperthermic radio(chemo)therapy
26. Update on quality assurance in neuropathology: Summary of the round robin trials on TERT promoter mutation, H3-3A mutation, 1p/19q codeletion, and KIAA1549::BRAF fusion testing in Germany in 2020 and 2021
27. Dynamics of the Intratumoral Immune Response during Progression of High-Grade Serous Ovarian Cancer
28. Intratumoral morphological heterogeneity can be an indicator of genetic heterogeneity in colorectal cancer
29. Erratum zu Mitteilungen der Deutschen Gesellschaft für Pathologie
30. Accuracy of diagnostic tests and a new algorithm for diagnosing cytomegalovirus colitis in inflammatory bowel diseases: a diagnostic study
31. Mesothelin as a target for cervical cancer therapy
32. The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma
33. Cytotoxic tumour-infiltrating T lymphocytes influence outcome in resected pancreatic ductal adenocarcinoma
34. Abstract 925: NTRK gene fusion in adults and pediatrics with solid tumors: a record linkage study of expression frequency and patient characteristics using the Auria Biobank in Finland
35. Abstract 926: Genomics-based personalized oncology of advanced thymic epithelial tumors
36. Supplementary Figures from Multilayered Omics-Based Analysis of a Head and Neck Cancer Model of Cisplatin Resistance Reveals Intratumoral Heterogeneity and Treatment-Induced Clonal Selection
37. supplementary file 2 from Multilayered Omics-Based Analysis of a Head and Neck Cancer Model of Cisplatin Resistance Reveals Intratumoral Heterogeneity and Treatment-Induced Clonal Selection
38. supplementary file 1 from Multilayered Omics-Based Analysis of a Head and Neck Cancer Model of Cisplatin Resistance Reveals Intratumoral Heterogeneity and Treatment-Induced Clonal Selection
39. supplementary information from Multilayered Omics-Based Analysis of a Head and Neck Cancer Model of Cisplatin Resistance Reveals Intratumoral Heterogeneity and Treatment-Induced Clonal Selection
40. supplementary file 3 from Multilayered Omics-Based Analysis of a Head and Neck Cancer Model of Cisplatin Resistance Reveals Intratumoral Heterogeneity and Treatment-Induced Clonal Selection
41. B-cell receptor–driven MALT1 activity regulates MYC signaling in mantle cell lymphoma
42. Lymphoproliferative Erkrankungen der Mundhöhle und des Waldeyer Rachenrings
43. Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomas
44. Bone Marrow Work-up: Report of a Pilot Study
45. Prevalence, Clinical and Molecular Features, and Prognostic Value of Tetraploidy/Near-Tetraploidy in Patients with Acute Myeloid Leukemia
46. Tomoelastography by multifrequency wave number recovery from time-harmonic propagating shear waves
47. Patient and treatment-related risk factors for osteoradionecrosis of the jaw in patients with head and neck cancer
48. Augmented liver inflammation in a microsomal prostaglandin E synthase 1 (mPGES-1)-deficient diet-induced mouse NASH model
49. Perturbations of mesenchymal stromal cells after allogeneic hematopoietic cell transplantation predispose for bone marrow graft-versus-host-disease
50. Course and outcome of chilblain‐like acral lesions during COVID ‐19 pandemic
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.